1-8 of 8
Yening Tan
Close
Sort by
Journal Articles

Memory Phenotype in Allogeneic Anti-BCMA CAR-T Cell Therapy (P-BCMA-ALLO1) Correlates with In Vivo Tumor Control

Hubert Tseng, Yan Zhang, Stacey A Cranert, Maximilian Richter, Karl Marquez, Jing Qiu, Benjamin Cho, Yening Tan, Min Tong, Christine Domingo, Leslie Weiss, Elvira Argus, Jessica Sparks, Eric M. Ostertag, Julia Coronella, Devon J Shedlock
Journal: Blood
Blood (2021) 138 (Supplement 1): 4802.
https://doi.org/10.1182/blood-2021-154034
Published: 2021
Journal Articles

Manufacture of an Allogeneic CAR-T Stem Cell Memory Product Candidate for Multiple Myeloma, P-Bcma-ALLO1, Is Robust, Reproducible and Highly Scalable

Stacey A Cranert, PhD, Maximilian Richter, PhD, Min Tong, MS, Leslie Weiss, MS, Yening Tan, MS, Eric M. Ostertag, MD PhD, Julia Coronella, PhD, Devon J Shedlock, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4445.
https://doi.org/10.1182/blood-2019-131839
Published: 2019
Journal Articles

The Application of ‘Drug-Reversible’ CAR-T Cells Directed Against Recipient Hematopoietic Cells As a Selective Conditioning Strategy for Stem Cell Transplantation

Nina Timberlake, Maximilian Richter, Xinxin Wang, PhD, Nicholas Cam, Yening Tan, Eric M Ostertag, Devon J Shedlock, Julian D Down
Journal: Blood
Blood (2017) 130 (Supplement 1): 1893.
https://doi.org/10.1182/blood.V130.Suppl_1.1893.1893
Published: 2017
Journal Articles

B-Cell Maturation Antigen (BCMA)-Specific, Centyrin TM -Based, PiggyBac TM -Transposed CAR-T Memory Stem Cells Are Effective Against p53 -/- and Patient-Derived Multiple Myeloma Tumors

Rohit Mathur, PhD, Burton Earle Barnett, PhD, David Hermanson, PhD, Jin He, Zheng Zhang, Srinivas Rengarajan, MS, Rebecca Codde, Xinxin Wang, PhD, Yening Tan, Christopher Martin, Jenessa Smith, Hans C. Lee, MD, Elisabet E. Manasanch, MD, Sheeba K. Thomas, MD, Krina K. Patel, MDMSc, Donna M. Weber, MD, R. Eric Davis, MD, Robert Z. Orlowski, MD PhD, Eric M Ostertag, Devon Shedlock, PhD, Jing Yang, PhD, Sattva S. Neelapu, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3068.
https://doi.org/10.1182/blood.V130.Suppl_1.3068.3068
Published: 2017
Journal Articles

Production of Universal Anti-Bcma CAR-T Cells with Reduced Alloreactivity, but Potent Effector Function for the Treatment of Multiple Myeloma

Xinxin Wang, PhD, Burton Earle Barnett, PhD, Christopher Martin, David Hermanson, PhD, Xianghong Li, Jenessa Smith, Joann Wu, Stacey Cranert, PhD, Srinivas Rengarajan, MS, Yening Tan, Min Tong, Rebecca Codde, Julian D Down, Eric M Ostertag, Devon J Shedlock
Journal: Blood
Blood (2017) 130 (Supplement 1): 503.
https://doi.org/10.1182/blood.V130.Suppl_1.503.503
Published: 2017
Journal Articles

A Novel Bcma-Specific, Centyrin-Based CAR-T Product for the Treatment of Multiple Myeloma

David L. Hermanson, PhD, Burton Earle Barnett, PhD, Srinivas Rengarajan, M.S., Rebecca Codde, B.S., Xinxin Wang, PhD, Yening Tan, B.S., Christopher E. Martin, PhD, Jenessa Barbara Smith, PhD, Jin He, M.S., Rohit Mathur, PhD, Jing Yan, PhD, Sattva S. Neelapu, MD, Eric M. Osertag, MD PhD, Devon J. Shedlock, PhD
Journal: Blood
Blood (2016) 128 (22): 2127.
https://doi.org/10.1182/blood.V128.22.2127.2127
Published: 2016
Journal Articles

piggyBac TM -Produced CAR-T Cells Exhibit Stem-Cell Memory Phenotype

Burton Earle Barnett, PhD, David L. Hermanson, PhD, Jenessa Barbara Smith, PhD, Xinxin Wang, PhD, Yening Tan, B.S., Christopher E. Martin, PhD, Eric M. Osertag, MD PhD, Devon J. Shedlock, PhD
Journal: Blood
Blood (2016) 128 (22): 2167.
https://doi.org/10.1182/blood.V128.22.2167.2167
Published: 2016
Journal Articles

Development of Novel Non-Immunoglobulin Centyrin-Based Cars (CARTyrins) Targeting Human Bcma

Burton Earle Barnett, PhD, Xinxin Wang, PhD, David L. Hermanson, PhD, Yening Tan, B.S., Eric M. Osertag, MD PhD, Devon J. Shedlock, PhD
Journal: Blood
Blood (2016) 128 (22): 4557.
https://doi.org/10.1182/blood.V128.22.4557.4557
Published: 2016